COMP <GO>
BLCO vs MRK // NET PROFIT MARGIN
Bausch + Lomb Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: BLCO 3
— MRK 12
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $20.00 (-1.96%) • MKT CAP: $7.29B
net-margins
-7.10%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLCO VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLCO | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 20.70% | -19.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.1x | 15.3x | +13.80 | MRK | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | 3.42% | -4.32 | MRK | /fcf-yield <GO> |
| Operating Margin | 2.20% | 34.30% | -32.10 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -7.10% | 28.10% | -35.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 1.30% | +5.20 | BLCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.97 | 5.19 | -4.22 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.60% | +0.50 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.8 | 56.9 | +16.99 | BLCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.92 | +0.14 | BLCO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 18.4x | +4.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.29B | $361.02B | -$353.73B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLCO REV | MRK REV | BLCO GROSS % | MRK GROSS % | BLCO FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.10B | $65.01B | 44.0% | 74.8% | -$66.0M | $12.36B |
| FY 2024 | $4.79B | $64.17B | 44.0% | 76.3% | -$59.0M | $18.10B |
| FY 2023 | $4.15B | $60.12B | 44.0% | 44.0% | -$203.6M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLCO // BETA 1.06
MRK // BETA 0.92